Home » Topics » Regulatory

Regulatory
RSS

FDA approves Emgality for preventive treatment of migraine in adults

Sep. 28, 2018

European Commission approves pegfilgrastim biosimilar Udenyca

Sep. 26, 2018

FDA grants approval for Copiktra for CLL/SLL, accelerated approval in follicular lymphoma

Sep. 25, 2018

Xospata approved in Japan for FLT3 mutation-positive relapsed or refractory AML

Sep. 25, 2018

Beova granted marketing approval in Japan for overactive bladder

Sep. 25, 2018

Eybelis granted marketing approval for glaucoma and ocular hypertension in Japan

Sep. 25, 2018

Lorlatinib receives first approval in Japan

Sep. 21, 2018

Hulio, a biosimilar to adalimumab, receives marketing authorization in Europe

Sep. 21, 2018

FDA approves Ajovy for preventive treatment of migraine

Sep. 17, 2018

FDA approves Lumoxiti for relapsed or refractory hairy cell leukemia

Sep. 14, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...